Ductal carcinoma in situ treated with breast‐conserving surgery and accelerated partial breast irradiation

Abstract

This study found that patients who met the criteria of E5194 treated with APBI had extremely low rates of recurrence (0% vs 6.1% in the LIG cohort and 5.3% vs 15.3% in the HG cohort).